Literature DB >> 7309782

Alkyl-lysophospholipids inhibit the growth of hypernephroid carcinomas in vitro.

W E Berdel, U Fink, B Egger, A Reichert, P G Munder, J Rastetter.   

Abstract

Synthetic alkyl-lysophospholipids (ALPs) inhibit the proliferation of human hypernephromas in vitro. Cells of ten different tumors were incubated with 4 ALPs for periods of more than 24h. Eight of ten cell lines showed proliferation rates below 1% of the controls after cultivation. One microgram of ALPs per 10(6) tumor cells was effective, in some experiments a dose response relation was found for even lower concentrations. Equivalent concentrations of cytostatic drugs did not show reproducible higher antitumor effects in vitro. In two of the tested cell lines ALPs did not show any reproducible tumor growth inhibition, whereas at least some of the cytostatic drugs revealed slight cytostatis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7309782     DOI: 10.1007/bf00410118

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  7 in total

1.  Selective destruction of human leukemic cells by alkyl-lysophospholipids.

Authors:  R Andreesen; M Modolell; H U Weltzien; H Eibl; H H Common; G W Löhr; P G Munder
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  The biocleavage of alkyl glyceryl ethers in Morris hepatomas and other transplantable neoplasms.

Authors:  J F Soodsma; C Piantadosi; F Snyder
Journal:  Cancer Res       Date:  1970-02       Impact factor: 12.701

3.  The occurrence and metabolism of alkyl and alk-1-enyl ethers of glycerol in transplantable rat and mouse tumors.

Authors:  F Snyder; R Wood
Journal:  Cancer Res       Date:  1968-05       Impact factor: 12.701

4.  Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues.

Authors:  F Snyder; R Wood
Journal:  Cancer Res       Date:  1969-01       Impact factor: 12.701

5.  The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinoma.

Authors:  W E Berdel; W R Bausert; H U Weltzien; M L Modolell; K H Widmann; P G Munder
Journal:  Eur J Cancer       Date:  1980-09       Impact factor: 9.162

6.  Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids.

Authors:  M Modolell; R Andreesen; W Pahlke; U Brugger; P G Munder
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

7.  Inhibition by alkyl-lysophospholipids of tritiated thymidine uptake in cells of human malignant urologic tumors.

Authors:  W E Berdel; U Fink; B Egger; A Reichert; P G Munder; J Rastetter
Journal:  J Natl Cancer Inst       Date:  1981-05       Impact factor: 13.506

  7 in total
  5 in total

1.  Antineoplastic activity of synthetic lysophospholipid analogs.

Authors:  W E Berdel
Journal:  Blut       Date:  1982-02

2.  Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantation.

Authors:  W R Vogler; A C Olson; S Okamoto; L B Somberg; L Glasser
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

3.  Response of acute myelomonocytic leukemia to alkyl-lysophospholipids. A case report.

Authors:  W E Berdel; U Fink; P A Maubach; B Permanetter; J Rastetter
Journal:  Blut       Date:  1982-03

4.  Synergistic enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by the ether lipid analogue BM41440, an inhibitor of protein kinase C.

Authors:  J Hofmann; F Ueberall; L Posch; K Maly; D B Herrmann; H Grunicke
Journal:  Lipids       Date:  1989-04       Impact factor: 1.880

5.  Comparison of selective cytotoxicity of alkyl lysophospholipids.

Authors:  W R Vogler; A C Olson; S Okamoto; M Shoji; R L Raynor; J F Kuo; W E Berdel; H Eibl; J Hajdu; H Nomura
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.